Key clinical point: In a new trial analysis, an implantable alert device relative to a sham identified silent MIs and avoided false positive ER visits.
Major finding: False-positive ER visits fell from 0.678 when device was off to 0.164/year (P less than .001) when device was activated.
Data source: ALERTS, a multicenter, randomized controlled trial
Disclosures: Dr. Gibson has financial relationships with many companies, including Angel Medical Systems, the sponsor of this trial.
REPORTING FROM CRT 2019